| parent | Antitubercular agents | LP31463-0 |
| child | Capreomycin 5.0 ug/mL | LP227883-8 |
| child | Capreomycin | Isolate | Antibiotic susceptibilities | LP380368-3 |
| child | Capreomycin | Isolate and Serum | Antibiotic susceptibilities | LP380370-9 |
| child | Capreomycin 3.0 ug/mL | LP227881-2 |
| child | Capreomycin 10.0 ug/mL | LP227879-6 |
| child | Capreomycin 20.0 ug/mL | LP227880-4 |
| child | Capreomycin 30.0 ug/mL | LP227882-0 |
| parent | Antitubercular agents | LP31463-0 |
| child | Capreomycin | Serum or Plasma | Drug toxicology | LP389117-5 |
| PartDisplayName | en-US | Capreomycin |
| DisplayName | en-US | Capreomycin |
LOINC Version: 2.77
FHIR